The Strategic Imperative of Metabolomics Biomarkers: Navigating Precision Medicine in a High-Growth Market As we approach 2026, the global metabolomics biomarker market stands at a critical inflection point. With a projected compound annual growth rate of 8.5% through 2032 and a market size expected to reach USD 1,681.15 million in 2026, this sector is no longer a niche scientific discipline...